Announcements Trials
Browse Landscape

Phase

Phase 1 10Phase NA 6Phase 1/2 4Phase 3 3Phase 2 3Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 497Terminated 126Unknown 35Recruiting 26Withdrawn 24Active not recruiting 21Not yet recruiting 3Suspended 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 2

Conditions

Carcinoma, Non-Small-Cell Lung 128Breast Neoplasms 95Colorectal Neoplasms 62Carcinoma, Hepatocellular 59Stomach Neoplasms 49Squamous Cell Carcinoma of Head and Neck 47Lung Neoplasms 44Prostatic Neoplasms 43Leukemia, Myeloid, Acute 43Triple Negative Breast Neoplasms 42Small Cell Lung Carcinoma 40Uterine Cervical Neoplasms 37Rectal Neoplasms 36Pancreatic Neoplasms 31Neoplasms 29Neoplasm Metastasis 29Recurrence 26Esophageal Squamous Cell Carcinoma 25Ovarian Neoplasms 23Esophageal Neoplasms 23Nasopharyngeal Carcinoma 21Brain Neoplasms 21Lymphoma, Large B-Cell, Diffuse 20Colonic Neoplasms 20Carcinoma, Renal Cell 20Melanoma 19Endometrial Neoplasms 19Biliary Tract Neoplasms 18Head and Neck Neoplasms 17Multiple Myeloma 16

Interventions

Cytarabine 2Cyclophosphamide 2venetoclax 1pegaspargase 1fludarabine 1etoposide phosphate 1blinatumomab 1Whole-Body Irradiation 1Vincristine 1Tacrolimus 1Mycophenolic Acid 1Methotrexate 1Mercaptopurine 1Etoposide 1Doxorubicin 1Dexamethasone 1Decitabine 1Calcium Dobesilate 1Busulfan 1Azacitidine 1Anthracyclines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Not yet recruiting × Leukemia × Clear all
NCT07524530 2026-05-27

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Not yet recruiting
98 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Hematologic Neoplasms

NCT07060001 2026-03-06

Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker

The Methodist Hospital Research Institute

Phase 2 Not yet recruiting
112 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT07227584 2025-11-12

ALL Backbone in AYAs

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting
67 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡